CRISPR/Cas9 genome-edited universal CAR T cells in patients with relapsed/refractory lymphoma

Guo, YL; Tong, C; Su, LP; Zhang, WY; Jia, HJ; Liu, Y; Yang, QM; Wu, ZQ; Wang, Y; Han, WD

Wu, ZQ; Wang, Y; Han, WD (通讯作者)，Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Biotherapeut, Beijing, Peoples R China.;Han, WD (通讯作者)，Soochow Univ, Natl Clin Res Ctr Hematol Dis, First Affiliated Hosp, Suzhou, Peoples R China.;Wu, ZQ; Wang, Y; Han, WD (通讯作者)，28 Fuxing Rd, Beijing, Peoples R China.

BLOOD ADVANCES, 2022; 6 (8): 2695

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索